Funding Opportunity

R01 funding mechanism to support discrete, specified, and circumscribed projects on novel molecular imaging approaches to establish high-resolution mapping of biomolecules in brain cells and regions during the course of aging and Alzheimer’s disease (AD). This FOA...

Preclinical, clinical and outcomes research aimed at increasing medical knowledge in alopecia areata, atopic dermatitis or vitiligo.

The goals of this program are to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle- Income Country (LMIC) Institutions, to enhance research capacity, and to build a network of researchers...

HIV-associated non-communicable diseases research at low- and middle-income country institutions (R21 clinical trial optional) funding opportunity.

EFSD/Lilly exploring and applying new strategies in diabetes expand the program. This supports diabetes research projects on potential strategies that can be implemented in Europe and rolled out in low and middle-income countries to favor the improvement of quality of care for people living with diabetes.

This aims to contribute to the development of stronger and more inclusive movements advocating for sexual reproductive health and rights in sub-Saharan Africa, south Asia and Middle East and north Africa (MENA) region.

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research to better understand the epidemiology and biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial...

Projects that will be considered for Pfizer support will focus on development of an algorithm or tool to guide the optimal treatment and support of patients with ALK re- arranged NSCLC.

Staying healthy call. This supports projects that set out a credible pathway to contributing to staying healthy in a rapidly changing society.

The Children’s Tumor Foundation invites letters of intent for its drug discovery initiative registered reports award program. This supports early-stage testing of candidate drug therapies for the treatment of neurofibromatosis.

Research addressing the most intractable issues in paediatric cancer. Projects should fall under the following research themes: developmental origins of paediatric cancers; drugging currently undruggable paediatric cancers; developing novel immunotherapies; or discovery and development of novel paediatric cancer drug targets.

Research grants to stimulate innovative research in challenging areas of future importance. You may apply for more than one grant or submit your application for more than one focus topic: Drug Discovery, Real time testing and sensors, Nanoparticle for nucleic acid...